You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic Canada does not review or control the content on the other website, and is not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site not be licensed for sale in Canada.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
SYMPLICITY™ BLOOD PRESSURE PROCEDURE
The Medtronic Symplicity blood pressure procedure provides another management option for people with uncontrolled high blood pressure.*1–3
The Symplicity blood pressure procedure calms excessively active nerves connected to the kidneys that may be contributing to your high blood pressure.4
The Symplicity blood pressure procedure usually only takes up one day of your schedule, and can be done on an outpatient basis with your doctor's approval.
See how the Symplicity blood pressure procedure has helped people manage their blood pressure.
Testimonials are individual experiences. Their thoughts and opinions are their own. Not every person will experience the same results.
Includes Symplicity Spyral™ and Flex catheters.
Through three years in a patient registry.
Kandzari DE, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. June 9, 2018;391(10137):2346–2355.
Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. May 2, 2020;395(10234):1444–1451.
Mahfoud F, Mancia G, Schmieder R, et al. Blood pressure and MACE reductions after renal denervation: 3-year Global Symplicity Registry results. Presented at PCR e-course 2022.
Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. March 5, 2016;387(10022):957–967.
Mahfoud F, Mancia G, Schmieder R, et al. Renal denervation in high-risk patients with hypertension. J Am Coll Cardiol. June 16, 2020;75(23):2879–2888.
Böhm M, Mahfoud F, Williams B, et al. Renal denervation with Symplicity Spyral™ catheter in the Global Symplicity Registry: Safety and efficacy at 3 years. Poster. TCT 2019.
Medtronic data on file.